Association Between Blood Pressure and Risk of PSCI

Recruiting

• Conditions: Stroke; Cognitive Decline; Blood Pressure

• Registration Number: NCT06730711
• Lead Sponsor: First Affiliated Hospital of Chongqing Medical University

Brief Summary

This retrospective cohort study was designed to explore the relationship between blood pressure and cognitive impairment after stroke

Detailed Description

Patients who have been followed up for more than 3 months after stroke will be included in the study. Basic data of patients and factors that may be related to cognitive impairment will be collected, and the relationship between blood pressure and cognitive impairment after stroke will be explored by univariate regression analysis and multivariate regression analysis. Univariate logistic regression model and multivariate logistic regression model were used to explore the relationship between blood pressure level and the risk of cognitive impairment after stroke, and the effect of blood pressure level and cognitive impairment sub-line in different patients was evaluated by subgroup analysis.

Study Timeline

• Study Start: 2024-09-01
• Status Verified: 2024-12
• Study First Submitted: 2024-12-02
• Study First Submitted QC: 2024-12-08
• Last Update Submitted: 2024-12-08
• Study First Posted: 2024-12-12
• Last Update Posted: 2024-12-12
• Primary Completion: 2024-12-20
• Study Completion: 2024-12-30

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 600

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Mental State Examination Scale (MMSE)	Mini-Mental State Examination (MMSE) assessment will be completeed at 3 monthes after stroke	Global cognitive function assessment. Easy to use and one of the most used scales to screen person with cognitive impairment in the world. The minimum and maximum values range from 0 to 30. Higher score means better cognition level.

Trial Locations

Locations (1)

First Affiliated Hospital of Chongqing Medical University; 🇨🇳 Chongqing, Chongqing, China